文献速递糖尿病肥胖与代谢综合征

胰岛素抵抗时肾皮质葡萄糖摄取降低并与血清游离脂肪酸呈负相关

Renal Cortical Glucose Uptake Is Decreased in Insulin Resistance and Correlates Inversely With Serum Free-fatty Acids.
PubMed 文献 · J Clin Endocrinol Metab · 2024-01-01

研究纳入18名肥胖者和18名非肥胖对照,在胰岛素钳夹期间用[18F]FDG PET测量肾葡萄糖摄取。肥胖者肾皮质葡萄糖摄取低于非肥胖对照(3.1 [2.2-4.3] vs 4.7 [3.4-5.6],P=.004),且与胰岛素敏感性正相关、与游离脂肪酸等负相关,提示肾皮质存在底物竞争。

要点

  • 肥胖者肾皮质葡萄糖摄取低于非肥胖对照(3.1 [2.2-4.3] vs 4.7 [3.4-5.6],P=.004)。
  • 肾皮质葡萄糖摄取与胰岛素敏感性M值正相关(r=0.42,P=.01)。
  • 肾皮质葡萄糖摄取与游离脂肪酸负相关(r=-0.68,P<.0001),提示底物竞争。

核心结论

  • 数据证实肥胖者与健康非肥胖对照之间肾皮质葡萄糖摄取存在差异。
  • 肾皮质葡萄糖摄取与游离脂肪酸、酮体和柠檬酸盐的负相关提示肾皮质存在底物竞争。

研究设计与样本

  • 研究纳入18名肥胖者和18名非肥胖对照,在胰岛素钳夹期间行[18F]FDG正电子发射断层扫描。
  • [18F]FDG注射后约60分钟获取肾脏扫描图像。
  • 肾葡萄糖摄取采用分数摄取率并在校正残留肾小管内[18F]FDG后测量。
  • 循环代谢物采用高通量质子核磁共振代谢组学测量。

主要发现

  • 健康非肥胖对照的肾皮质葡萄糖摄取高于肥胖者(4.7 [3.4-5.6] vs 3.1 [2.2-4.3],P=.004)。
  • 肾皮质葡萄糖摄取与胰岛素敏感性程度(M值)正相关(r=0.42,P=.01)。
  • 肾皮质葡萄糖摄取与循环β-羟丁酸(r=-0.58,P=.009)、乙酰乙酸(r=-0.48,P=.008)、柠檬酸盐(r=-0.44,P=.01)和游离脂肪酸(r=-0.68,P<.0001)负相关,即使校正M值后仍存在。
  • 肾髓质葡萄糖摄取与任何临床参数均无关联。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Studies on human renal metabolism are scanty. Nowadays, functional imaging allows the characterization of renal metabolism in a noninvasive manner. We have recently demonstrated that fluorodeoxyglucose F18 (18F FDG) positron emission tomography can be used to analyze renal glucose uptake (GU) rates, and that the renal cortex is an insulin-sensitive tissue. OBJECTIVE: To confirm that renal GU is decreased in people with obesity and to test whether circulating metabolites are related to renal GU. DESIGN, SETTING AND PARTICIPANTS: Eighteen people with obesity and 18 nonobese controls were studied with [18F]FDG positron emission tomography during insulin clamp. Renal scans were obtained ∼60 minutes after [18F]FDG injection. Renal GU was measured using fractional uptake rate and after correcting for residual intratubular [18F]FDG. Circulating metabolites were measured using high-throughput proton nuclear magnetic resonance metabolomics. RESULTS: Cortical GU was higher in healthy nonobese controls compared with people with obesity (4.7 [3.4-5.6] vs 3.1 [2.2-4.3], P = .004, respectively), and it associated positively with the degree of insulin sensitivity (M value) (r = 0.42, P = .01). Moreover, cortical GU was inversely associated with circulating β-OH-butyrate (r = -0.58, P = .009), acetoacetate (r = -0.48, P = .008), citrate (r = -0.44, P = .01), and free fatty acids (r = -0.68, P < .0001), even when accounting for the M value. On the contrary, medullary GU was not associated with any clinical parameters. CONCLUSION: These data confirm differences in renal cortical GU between people with obesity and healthy nonobese controls. Moreover, the negative correlations between renal cortex GU and free fatty acids, ketone bodies, and citrate are suggestive of substrate competition in the renal cortex.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Rebelos E, Mari A, Honka MJ, et al. Renal Cortical Glucose Uptake Is Decreased in Insulin Resistance and Correlates Inversely With Serum Free-fatty Acids. J Clin Endocrinol Metab. 2024. PMID: 37955868. doi:10.1210/clinem/dgad663

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。